Artal Group as of Dec. 31, 2021
Portfolio Holdings for Artal Group
Artal Group holds 149 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Lexicon Pharmaceuticals Com New (LXRX) | 7.6 | $280M | 71M | 3.94 | |
Ww Intl (WW) | 6.5 | $239M | 15M | 16.13 | |
Mirati Therapeutics | 5.6 | $205M | 1.4M | 146.69 | |
Beigene Sponsored Adr | 5.0 | $183M | 675k | 270.93 | |
Argenx Se Sponsored Adr (ARGX) | 4.8 | $175M | 500k | 350.19 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 3.0 | $112M | 1.0M | 111.96 | |
Alnylam Pharmaceuticals (ALNY) | 3.0 | $110M | 650k | 169.58 | |
Seer Com Cl A (SEER) | 2.9 | $108M | 4.8M | 22.81 | |
Fate Therapeutics (FATE) | 2.9 | $105M | 1.8M | 58.51 | |
Seagen | 2.1 | $77M | 500k | 154.60 | |
Morphic Hldg (MORF) | 2.0 | $75M | 1.6M | 47.38 | |
Amicus Therapeutics (FOLD) | 1.9 | $69M | 6.0M | 11.55 | |
Bellus Health Com New | 1.9 | $68M | 8.5M | 8.05 | |
Kymera Therapeutics (KYMR) | 1.7 | $64M | 1.0M | 63.49 | |
Bristol Myers Squibb Call Option (BMY) | 1.7 | $62M | 1.0M | 62.35 | |
Scholar Rock Hldg Corp (SRRK) | 1.7 | $61M | 2.5M | 24.84 | |
Citigroup Com New Call Option (C) | 1.6 | $60M | 1.0M | 60.39 | |
Sage Therapeutics (SAGE) | 1.4 | $53M | 1.3M | 42.54 | |
Springworks Therapeutics (SWTX) | 1.4 | $53M | 850k | 61.98 | |
Erasca (ERAS) | 1.3 | $49M | 3.2M | 15.58 | |
Krystal Biotech (KRYS) | 1.3 | $49M | 700k | 69.95 | |
Cerevel Therapeutics Hldng I (CERE) | 1.3 | $49M | 1.5M | 32.42 | |
Cytokinetics Com New (CYTK) | 1.2 | $46M | 1.0M | 45.58 | |
Igm Biosciences (IGMS) | 1.2 | $44M | 1.5M | 29.33 | |
Protagonist Therapeutics (PTGX) | 1.2 | $43M | 1.3M | 34.20 | |
I Mab Sponsored Ads (IMAB) | 1.1 | $40M | 850k | 47.39 | |
Foghorn Therapeutics (FHTX) | 1.1 | $39M | 1.7M | 22.87 | |
Rubius Therapeutics | 1.0 | $36M | 3.7M | 9.68 | |
Intellia Therapeutics (NTLA) | 0.9 | $33M | 275k | 118.24 | |
Talaris Therapeutics | 0.9 | $32M | 2.1M | 15.29 | |
Allovir (ALVR) | 0.8 | $30M | 2.3M | 12.94 | |
Evotec Sponsored Ads (EVO) | 0.7 | $27M | 1.1M | 23.75 | |
Eqrx | 0.7 | $27M | 4.0M | 6.82 | |
Denali Therapeutics (DNLI) | 0.7 | $27M | 600k | 44.60 | |
Gossamer Bio (GOSS) | 0.7 | $27M | 2.4M | 11.31 | |
Omega Therapeutics Common Stock (OMGA) | 0.7 | $26M | 2.3M | 11.33 | |
Iteos Therapeutics (ITOS) | 0.7 | $25M | 544k | 46.56 | |
Replimune Group (REPL) | 0.7 | $24M | 900k | 27.10 | |
Schrodinger (SDGR) | 0.7 | $24M | 700k | 34.83 | |
Atara Biotherapeutics | 0.6 | $24M | 1.5M | 15.76 | |
Praxis Precision Medicines I | 0.6 | $24M | 1.2M | 19.70 | |
Relay Therapeutics (RLAY) | 0.6 | $23M | 750k | 30.71 | |
Aurinia Pharmaceuticals (AUPH) | 0.6 | $23M | 1.0M | 22.87 | |
Vertex Pharmaceuticals Incorporated Call Option (VRTX) | 0.6 | $22M | 100k | 219.60 | |
Kronos Bio (KRON) | 0.6 | $21M | 1.5M | 13.59 | |
Agenus Com New | 0.6 | $21M | 6.5M | 3.22 | |
Generation Bio (GBIO) | 0.5 | $20M | 2.8M | 7.08 | |
Ambrx Biopharma Sponsored Ads | 0.5 | $19M | 2.2M | 9.03 | |
Ikena Oncology (IKNA) | 0.5 | $19M | 1.5M | 12.54 | |
Novagold Res Com New (NG) | 0.5 | $18M | 2.6M | 6.86 | |
Aptinyx | 0.4 | $16M | 6.1M | 2.67 | |
Intel Corporation Call Option (INTC) | 0.4 | $16M | 300k | 51.50 | |
Tg Therapeutics (TGTX) | 0.4 | $15M | 800k | 19.00 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $15M | 700k | 21.09 | |
Verve Therapeutics (VERV) | 0.4 | $15M | 400k | 36.87 | |
Kura Oncology (KURA) | 0.4 | $15M | 1.1M | 14.00 | |
Sqz Biotech (SQZB) | 0.4 | $14M | 1.6M | 8.93 | |
Forma Therapeutics Hldgs SHS | 0.4 | $14M | 1.0M | 14.22 | |
Albireo Pharma | 0.4 | $14M | 600k | 23.29 | |
Selecta Biosciences | 0.4 | $13M | 4.0M | 3.26 | |
Leap Therapeutics | 0.4 | $13M | 4.0M | 3.24 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $12M | 1.0M | 11.65 | |
Oatly Group Ab Sponsored Ads (OTLY) | 0.3 | $12M | 1.5M | 7.96 | |
Turning Point Therapeutics I | 0.3 | $12M | 250k | 47.70 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.3 | $12M | 1.0M | 11.88 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $11M | 2.3M | 5.01 | |
Exscientia Ads (EXAI) | 0.3 | $11M | 550k | 19.76 | |
Alx Oncology Hldgs (ALXO) | 0.3 | $11M | 500k | 21.49 | |
Syros Pharmaceuticals | 0.3 | $9.8M | 3.0M | 3.26 | |
Gritstone Oncology Ord (GRTSQ) | 0.3 | $9.6M | 750k | 12.86 | |
Black Diamond Therapeutics (BDTX) | 0.2 | $8.8M | 1.6M | 5.33 | |
Graphite Bio | 0.2 | $8.7M | 700k | 12.43 | |
Design Therapeutics (DSGN) | 0.2 | $8.6M | 400k | 21.41 | |
Alpine Immune Sciences | 0.2 | $8.2M | 593k | 13.85 | |
Nanobiotix Sa Sponsored Ads (NBTX) | 0.2 | $8.1M | 1.0M | 8.10 | |
Adagene Ads (ADAG) | 0.2 | $8.1M | 1.0M | 8.07 | |
Ovid Therapeutics (OVID) | 0.2 | $8.0M | 2.5M | 3.21 | |
Spero Therapeutics (SPRO) | 0.2 | $8.0M | 500k | 16.01 | |
Instil Bio | 0.2 | $7.7M | 450k | 17.11 | |
Harpoon Therapeutics | 0.2 | $7.6M | 1.0M | 7.55 | |
Mersana Therapeutics (MRSN) | 0.2 | $7.5M | 1.2M | 6.22 | |
Zymeworks | 0.2 | $7.4M | 450k | 16.39 | |
Omega Alpha Spac Cl A | 0.2 | $7.3M | 750k | 9.77 | |
Xilio Therapeutics (XLO) | 0.2 | $7.2M | 450k | 16.00 | |
Immunocore Hldgs Ads (IMCR) | 0.2 | $6.8M | 200k | 34.24 | |
Immunic (IMUX) | 0.2 | $6.7M | 700k | 9.57 | |
Y Mabs Therapeutics (YMAB) | 0.2 | $6.5M | 400k | 16.21 | |
Vor Biopharma (VOR) | 0.2 | $6.4M | 550k | 11.62 | |
Dyne Therapeutics (DYN) | 0.2 | $6.2M | 525k | 11.89 | |
Sana Biotechnology (SANA) | 0.2 | $6.2M | 400k | 15.48 | |
Curis Com New | 0.2 | $6.2M | 1.3M | 4.76 | |
Caribou Biosciences (CRBU) | 0.2 | $6.1M | 405k | 15.09 | |
Evelo Biosciences | 0.2 | $6.1M | 1.0M | 6.07 | |
Stoke Therapeutics (STOK) | 0.2 | $6.0M | 250k | 23.99 | |
Avidity Biosciences Ord (RNA) | 0.2 | $5.9M | 250k | 23.77 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $5.9M | 400k | 14.70 | |
Neximmune | 0.2 | $5.5M | 1.2M | 4.61 | |
Lyell Immunopharma (LYEL) | 0.1 | $5.4M | 700k | 7.74 | |
Adverum Biotechnologies | 0.1 | $5.3M | 3.0M | 1.76 | |
Solid Biosciences | 0.1 | $5.3M | 3.0M | 1.75 | |
Mirion Technologies Com Cl A (MIR) | 0.1 | $5.2M | 500k | 10.47 | |
Aeglea Biotherapeutics | 0.1 | $5.0M | 1.0M | 4.75 | |
Ac Immune Sa SHS (ACIU) | 0.1 | $5.0M | 1.0M | 4.95 | |
Dynamics Special Purpose Cor Class A Com | 0.1 | $4.9M | 500k | 9.86 | |
Cyclerion Therapeutics | 0.1 | $4.8M | 2.8M | 1.72 | |
GDS HLDGS Sponsored Ads (GDS) | 0.1 | $4.7M | 100k | 47.16 | |
Iqiyi Sponsored Ads (IQ) | 0.1 | $4.6M | 1.0M | 4.56 | |
Cardiff Oncology (CRDF) | 0.1 | $4.5M | 750k | 6.01 | |
23andme Holding Class A Com | 0.1 | $4.4M | 661k | 6.66 | |
Bridgebio Pharma (BBIO) | 0.1 | $4.2M | 250k | 16.68 | |
Contrafect Corp Com New | 0.1 | $3.9M | 1.5M | 2.63 | |
Phathom Pharmaceuticals (PHAT) | 0.1 | $3.9M | 200k | 19.67 | |
Cullinan Oncology (CGEM) | 0.1 | $3.9M | 250k | 15.43 | |
Portage Fintech Acquisitn Class A Ord Shs | 0.1 | $3.8M | 380k | 9.95 | |
Applied Therapeutics (APLT) | 0.1 | $3.6M | 400k | 8.95 | |
Tcr2 Therapeutics Inc cs | 0.1 | $3.5M | 750k | 4.66 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $3.4M | 200k | 17.13 | |
111 Ads (YI) | 0.1 | $3.4M | 966k | 3.50 | |
Immutep Sponsored Ads (IMMP) | 0.1 | $3.3M | 1.0M | 3.28 | |
Wave Life Sciences SHS (WVE) | 0.1 | $3.1M | 1.0M | 3.14 | |
Fusion Pharmaceuticals | 0.1 | $3.1M | 750k | 4.17 | |
Chinook Therapeutics | 0.1 | $2.9M | 181k | 16.31 | |
Aravive | 0.1 | $2.9M | 1.3M | 2.19 | |
Mei Pharma Com New | 0.1 | $2.7M | 1.0M | 2.67 | |
Olema Pharmaceuticals (OLMA) | 0.1 | $2.4M | 261k | 9.36 | |
Mereo Biopharma Group Ads (MREO) | 0.1 | $2.4M | 1.5M | 1.60 | |
Orchard Therapeutics Ads | 0.1 | $2.4M | 1.8M | 1.32 | |
Codiak Biosciences | 0.1 | $2.2M | 200k | 11.14 | |
Kinnate Biopharma | 0.1 | $2.2M | 125k | 17.72 | |
Hippo Hldgs Common Stock | 0.0 | $1.7M | 600k | 2.83 | |
Amryt Pharma Sponsored Ads | 0.0 | $1.6M | 151k | 10.80 | |
Axcella Health Inc equity | 0.0 | $1.5M | 713k | 2.09 | |
Hookipa Pharma Inc equity | 0.0 | $1.4M | 600k | 2.33 | |
Mink Therapeutics (INKT) | 0.0 | $1.3M | 290k | 4.46 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.3M | 111k | 11.66 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $1.2M | 500k | 2.41 | |
Kaleido Biosciences Ord (KLDO) | 0.0 | $1.2M | 501k | 2.39 | |
Lava Therapeutics Nv SHS (LVTX) | 0.0 | $1.1M | 200k | 5.50 | |
Deciphera Pharmaceuticals | 0.0 | $977k | 100k | 9.77 | |
Rigel Pharmaceuticals Com New | 0.0 | $851k | 321k | 2.65 | |
Sigilon Therapeutics | 0.0 | $762k | 276k | 2.76 | |
Marrone Bio Innovations | 0.0 | $755k | 1.0M | 0.72 | |
Rivian Automotive Com Cl A (RIVN) | 0.0 | $726k | 7.0k | 103.71 | |
Dlocal Class A Com (DLO) | 0.0 | $714k | 20k | 35.70 | |
Yumanity Therapeutics | 0.0 | $643k | 217k | 2.96 | |
Metacrine Ord | 0.0 | $624k | 925k | 0.67 | |
Surface Oncology | 0.0 | $478k | 100k | 4.78 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $285k | 225k | 1.27 | |
Astria Therapeutics (ATXS) | 0.0 | $180k | 33k | 5.40 |